Cargando…

Spatial and temporal genetic heterogeneity of epidermal growth factor receptor gene status in a patient with non-small cell lung cancer: a case report

INTRODUCTION: To date, an epidermal growth factor receptor-activating mutation is recognized as a genetic hallmark that predicts a good response to treatment with epidermal growth factor receptor tyrosine kinase inhibitor. However, there has been less long-term observation of the mutational status w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogata, Makoto, Shimizu, Toshiki, Yokoi, Takashi, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235080/ https://www.ncbi.nlm.nih.gov/pubmed/22108465 http://dx.doi.org/10.1186/1752-1947-5-553

Ejemplares similares

Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation
por: Kurata, Takayasu, et al.
Publicado: (2017)

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer
por: SHIMIZU, TOSHIKI, et al.
Publicado: (2013)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
por: YOKOI, TAKASHI, et al.
Publicado: (2014)

New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2017)

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy
por: KIBATA, KAYOKO, et al.
Publicado: (2013)

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer
por: Nakatani, Yuki, et al.
Publicado: (2017)

Retrospective analysis of single-agent nab-paclitaxel in patients with platinum-resistant non-small cell lung cancer
por: Nakaya, Aya, et al.
Publicado: (2017)

Antiplatelet antibody may cause delayed transfusion-related acute lung injury
por: Torii, Yoshitaro, et al.
Publicado: (2011)

Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer
por: Nakaya, Aya, et al.
Publicado: (2016)

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2018)

The genetics of phenotypic plasticity. XII. Temporal and spatial heterogeneity
por: Scheiner, Samuel M
Publicado: (2013)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
por: Nakaya, Aya, et al.
Publicado: (2018)

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature
por: INAGAKI, NORIKO, et al.
Publicado: (2013)

METHYLATION STATUS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE IN LUNG CARCINOMA CELLS
por: Gamou, Shinobu, et al.
Publicado: (1988)

Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms
por: Bourdeleau, Pauline, et al.
Publicado: (2023)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
por: Giannopoulou, Efstathia, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
por: Bhatt, Vijaya Raj, et al.
Publicado: (2016)

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
por: Nomura, Shosaku, et al.
Publicado: (2011)

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis
por: Ishii, Nobuyasu, et al.
Publicado: (2021)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Efficacy of gefapixant, a P2X(3) antagonist, for lung cancer-related cough: a case report
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

A warning related to predicting the severity of COVID-19 pneumonia using the A-DROP scoring system
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical features of nursing and healthcare-associated pneumonia due to COVID-19
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Spatial and Temporal Confined Photothermolysis of Cancer Cells Mediated by Hollow Gold Nanospheres Targeted to Epidermal Growth Factor Receptors
por: Ku, Geng, et al.
Publicado: (2018)

The Autocrine Loop of Epidermal Growth Factor Receptor‐Epidermal Growth Factor/Transforming Growth Factor‐α in Malignant Rhabdoid Tumor Cell Lines: Heterogeneity of Autocrine Mechanism in TTC549
por: Narita, Tsutomu, et al.
Publicado: (2001)

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
por: Lee, Dae Ho, et al.
Publicado: (2015)

Spatial intratumor heterogeneity of genetic, epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma
por: Hao, Jia-Jie, et al.
Publicado: (2016)

Spatially and Temporally Resolved Heterogeneities in a Miscible Polymer Blend
por: Zhang, Guofeng, et al.
Publicado: (2020)

Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes
por: Hilscher, Markus M., et al.
Publicado: (2022)

Examination of biomarker expressions in sepsis-related DIC patients
por: Shimizu, Michiomi, et al.
Publicado: (2018)

Effects of Temporal Heterogeneity of Water Supply and Spatial Heterogeneity of Soil Nutrients on the Growth and Intraspecific Competition of Bolboschoenus yagara Depend on Plant Density
por: Yu, Hongwei, et al.
Publicado: (2019)

Heterogeneity of the resistance to gefitinib treatment in a non‐small cell lung cancer patient with active epidermal growth factor receptor mutation
por: Xu, Chong‐Rui, et al.
Publicado: (2016)

Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival of Advanced Non-Small Cell Lung Cancer Harboring Mutant Epidermal Growth Factor Receptor
por: Minami, Seigo, et al.
Publicado: (2017)

Spatial Regulation of Epidermal Growth Factor Receptor Signaling by Endocytosis
por: Ceresa, Brian P.
Publicado: (2012)

Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
por: Huang, HM, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4emi3v1rge436frt2fpj8k1jah